Erlotinib or capecitabine with gemcitabine in pancreatic cancer?

By de Jager Jenny   Stebbing Justin  

Future Oncology, Vol. 2, Iss. 2, 2006-04 ,pp. : 161-163

Future Medicine

Access to resources Recommend Favorite

The Cost of Treating Pancreatic Cancer

By Hjelmgren Jonas   Ceberg Jeanette   Persson Ulf   Alvegård Thor A.  

Acta Oncologica, Vol. 42, Iss. 3, 2003-01 ,pp. : 218-226

Informa Healthcare

Access to resources Recommend Favorite

Gemcitabine-radiotherapy in patients with locally advanced pancreatic cancer

By de Lange S.M.   van Groeningen C.J.   Meijer O.W.M.   Cuesta M.A.   Langendijk J.A.   van Riel J.M.G.H.   Pinedo H.M.   Peters G.J.   Meijer S.   Slotman B.J.   Giaccone G.  

European Journal of Cancer, Vol. 38, Iss. 9, 2002-06 ,pp. : 1212-1217

Elsevier

Access to resources Recommend Favorite

Gemcitabine: A Review of its Use in the Management of Pancreatic Cancer

By Frampton James E.   Wagstaff Antona J.  

American Journal of Cancer, Vol. 4, Iss. 6, 2005-01 ,pp. : 395-416

Adis International

Access to resources Recommend Favorite

Bufalin enhances the antitumor effect of gemcitabine in pancreatic cancer

By            

Oncology Letters, Vol. 4, Iss. 4, 2012-01 ,pp. : 792-798

Spandidos Publications

Access to resources Recommend Favorite